News
The $5,000 equipment grant from the Education Foundation of Kennebunk and Arundel has transformed how students learn ...
Researchers used digital polymerase chain reaction assays to measure BRAF V600E or BRAF V600K circulating tumor DNA in ...
21h
HealthDay on MSNCirculating Tumor DNA Can ID Outcomes for Patients With MelanomaDroplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify ...
The global biological PCR technology market size is calculated at USD 15.68 billion in 2025 and is expected to reach around USD 28.93 billion by 2034, growing at a CAGR of 7.04% for the forecasted ...
Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial vaginosis (BV) during their lifetime. BV is characterized by unpleasant odors, ...
Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests ...
Monitoring circulating tumor DNA levels before and during treatment may predict melanoma recurrence, offering a potential ...
STONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc.(NASDAQ:APDN) (Applied DNA), a leader in ...
"If we look back to the O.J. Simpson case, actually, we saw the introduction of a new technology called PCR-based testing, which is now the gold standard for forensic DNA testing," he said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results